Primecap Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-65,990
Closed -$3.43M 331
2025
Q2
$3.43M Buy
65,990
+22,304
+51% +$996K ﹤0.01% 296
2025
Q1
$1.86M Hold
43,686
﹤0.01% 308
2024
Q4
$1.33M Sell
43,686
-22,490
-34% -$633K ﹤0.01% 314
2024
Q3
$1.52M Hold
66,176
﹤0.01% 315
2024
Q2
$1.91M Hold
66,176
﹤0.01% 307
2024
Q1
$1.37M Sell
66,176
-53,800
-45% -$1.15M ﹤0.01% 318
2023
Q4
$3.25M Hold
119,976
﹤0.01% 298
2023
Q3
$3.56M Sell
119,976
-3,000
-2% -$105K ﹤0.01% 293
2023
Q2
$4.4M Sell
122,976
-58,068
-32% -$1.67M ﹤0.01% 289
2023
Q1
$4.24M Sell
181,044
-21,000
-10% -$600K ﹤0.01% 288
2022
Q4
$5.5M Sell
202,044
-27,000
-12% -$1.24M 0.01% 272
2022
Q3
$12.3M Hold
229,044
0.01% 237
2022
Q2
$9.24M Buy
229,044
+21,476
+10% +$1.06M 0.01% 257
2022
Q1
$13.7M Buy
207,568
+10,916
+6% +$747K 0.01% 248
2021
Q4
$19.7M Hold
196,652
0.01% 243
2021
Q3
$24.6M Buy
196,652
+55,700
+40% +$6.62M 0.02% 230
2021
Q2
$17.5M Hold
140,952
0.01% 243
2021
Q1
$21.5M Buy
140,952
+12,900
+10% +$1.95M 0.02% 235
2020
Q4
$16.5M Buy
128,052
+124,602
+3,612% +$14.3M 0.01% 239
2020
Q3
$386K Buy
+3,450
New +$316K ﹤0.01% 308

Other funds holding GH

Primecap Management's GH Position: Q3 2025 in Review

Primecap Management sold out of Guardant Health (GH) in Q3 2025, closing a stake of 65,990 shares — an estimated $3.43M sold.

Primecap Management first reported a position in GH in Q3 2020 and held it in 20 quarters. The position peaked at $24.6M in Q3 2021. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Primecap Management reported no remaining Guardant Health position as of Q3 2025 after selling out during the quarter.
  • Primecap Management sold 65,990 Guardant Health shares in Q3 2025, an estimated $3.43M.
  • Primecap Management first reported a position in Guardant Health in Q3 2020 and held it in 20 quarters.
  • Primecap Management's Guardant Health position peaked at $24.6M in Q3 2021.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Primecap Management's 13F filing for Q3 2025, filed 12 Nov 2025.